000 01555nam  2200361zi 4500
0019.923513
003CaOODSP
00520240125150852
006m     o  d f      
007cr mn|||||||||
008230602t20232023onca    obs  f000 0 eng d
020 |a9780660490021
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
045 |ay2y2
0861 |aH134-33/2023E-PDF
24500|aOnline new psychoactive substances survey : |bsurveillance highlights, March 2020 to March 2023.
264 1|a[Ottawa] : |bHealth Canada = Santé Canada, |c2023.
264 4|c©2023
300 |a1 online resource (1 page) : |bcolour illustrations
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Enquête en ligne sur les nouvelles substances psychoactives (NSP) : points saillants, de mars 2020 à mars 2023.
500 |a"Pub.: 230100."
650 0|aPsychotropic drugs|zCanada|vStatistics.
650 0|aDrug abuse|zCanada|vStatistics.
655 7|aStatistics|2lcgft
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tEnquête en ligne sur les nouvelles substances psychoactives (NSP) : |w(CaOODSP)9.923514
85640|qPDF|s315 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H134-33-2023-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/publications/healthy-living/online-new-psychoactive-substances-survey-march-2020-march-2023.html